EA202090330A1 - COMPOSITIONS AND METHODS FOR TREATING DISORDERS RELATED TO STRESS - Google Patents

COMPOSITIONS AND METHODS FOR TREATING DISORDERS RELATED TO STRESS

Info

Publication number
EA202090330A1
EA202090330A1 EA202090330A EA202090330A EA202090330A1 EA 202090330 A1 EA202090330 A1 EA 202090330A1 EA 202090330 A EA202090330 A EA 202090330A EA 202090330 A EA202090330 A EA 202090330A EA 202090330 A1 EA202090330 A1 EA 202090330A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
methods
stress
disorders related
treating disorders
Prior art date
Application number
EA202090330A
Other languages
Russian (ru)
Inventor
Стивен Хоффман
Джон Ротман
Original Assignee
Хоффман Текнолоджиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хоффман Текнолоджиз, Инк. filed Critical Хоффман Текнолоджиз, Инк.
Priority claimed from PCT/US2018/042874 external-priority patent/WO2019018633A1/en
Publication of EA202090330A1 publication Critical patent/EA202090330A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится в основном к композициям, наборам и способам лечения связанных со стрессом расстройств, включая, но не ограничиваясь ими, посттравматическое стрессовое расстройство.The present invention relates generally to compositions, kits and methods for treating stress-related disorders, including, but not limited to, post-traumatic stress disorder.

EA202090330A 2018-02-09 2018-07-19 COMPOSITIONS AND METHODS FOR TREATING DISORDERS RELATED TO STRESS EA202090330A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862628687P 2018-02-09 2018-02-09
PCT/US2018/042874 WO2019018633A1 (en) 2017-07-19 2018-07-19 Compositions for treating stress-related disorders

Publications (1)

Publication Number Publication Date
EA202090330A1 true EA202090330A1 (en) 2020-06-02

Family

ID=71138791

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090330A EA202090330A1 (en) 2018-02-09 2018-07-19 COMPOSITIONS AND METHODS FOR TREATING DISORDERS RELATED TO STRESS

Country Status (1)

Country Link
EA (1) EA202090330A1 (en)

Similar Documents

Publication Publication Date Title
PH12021550337A1 (en) Anti-gdf15 antibodies, compositions and methods of use
EA201991862A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
EA202190983A1 (en) NEW ANTIBODY TO C-KIT
PH12019502283A1 (en) Anti-lag3 antibodies
EA201891910A1 (en) PAD4 HETEROARYLINARY INHIBITORS
PH12019501973A1 (en) Anti-phf-tau antibodies and uses thereof
EA202092435A2 (en) MONOCLONAL ANTIBODIES AGAINST BCMA
EA201892147A1 (en) BICYCLIC COMPOUNDS
EA201891532A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF HEMOGLOBINOPATHY
MX2019003623A (en) Compositions and methods for treating ophthalmic conditions.
EA201792467A1 (en) HETERODIMERNYE ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
EA201991720A1 (en) ANTIBODIES TO ALPHA-SINUCLEIN AND THEIR APPLICATIONS
PH12020550023A1 (en) Compositions for treating stress-related disorders
EA202190609A1 (en) ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS OF APPLICATION ANTIBODIES AGAINST HLA-G
EA201891539A1 (en) METALLIC ENZYME INHIBITING COMPOUNDS
EA201891251A1 (en) PAD4 BICYCLIC INHIBITORS
PH12018502137A1 (en) Anti-complement factor bb antibodies and uses thereof
EA201992232A1 (en) COMPOSITIONS AND METHODS FOR IMMUNOUNCOLOGY
MX2020010951A (en) Anti-hla-g antibodies and use thereof.
EA201891347A1 (en) Aza-benzimidazole inhibitors PAD4
EA202091731A1 (en) AUTOTAXIN INHIBITORS AND THEIR APPLICATIONS
MX2018009325A (en) Compounds and methods of treating rna-mediated diseases.
EA201891468A1 (en) COMPOSITIONS AND METHODS TO REDUCE TAU EXPRESSION
MX2021016098A (en) Humanized antibody molecules to cd138 and uses thereof.
EA202090513A1 (en) AGENTS MODULATING THE FUNCTIONS OF BETA-CATENIN AND RELATED METHODS